AUA 2011 - Effect of long-acting testosterone injections for treatment of hypogonadism after brachytherapy for prostate cancer - Session Highlights

WASHINGTON, DC USA (UroToday.com) -The research group evaluated the effect of long-acting testosterone injection for treatment of hypogonadism after brachytherapy for prostate cancer. In this small group of patients post –brachytherapy treatment replacement therapy with long-acting testosterone injections, the testosterone injections had a positive impact on symptoms of hypogonadism and erectile function without short-term PSA progression.

 

 

Presented by F. Balbontin, et al. at the American Urological Association (AUA) Annual Meeting - May 14 - 19, 2011 - Walter E. Washington Convention Center, Washington, DC USA


Reported for UroToday by Pamela Ellsworth, MD, Associate Professor of Urology/Surgery and Pediatrics at the Warren Alpert Medical School at Brown University, Providence, Rhode Island.


 

The opinions expressed in this article are those of the UroToday.com Contributing Editor and do not necessarily reflect the viewpoints of the American Urological Association.


 

 



View Full AUA 2011 Meeting Coverage





email news signup